Discontinued — last reported Q4 '25
Debt Repayments
FinancingEli Lilly Debt Repayments remained flat by 0.0% to $194.50M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 17.1%, from $166.05M to $194.50M. Over 4 years (FY 2021 to FY 2025), Debt Repayments shows a downward trend with a -20.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryLeverage
SignalHigher is better
VolatilityModerate
First reportedQ1 2012
Last reportedQ4 2025
How to read this metric
An increase signals a focus on deleveraging and strengthening the balance sheet, which reduces financial risk.
Detailed definition
The total cash outflow used to retire or pay down outstanding principal on loans, bonds, or other credit facilities. Thi...
Peer comparison
Investors track this alongside debt issuance to determine the 'net' change in a company's total debt load.
Metric ID:
cf_debt_repaymentHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $1.91B | $100.00K | $710.10M | $849.90M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $166.05M | $166.05M | $166.05M | $166.05M | $194.50M | $194.50M | $194.50M | $194.50M |
| QoQ Change | — | — | -100.0% | >999% | +19.7% | -100.0% | — | — | — | — | — | — | +0.0% | +0.0% | +0.0% | +17.1% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | — | -100.0% | -100.0% | -100.0% | -100.0% | — | — | — | — | — | — | +17.1% | +17.1% | +17.1% | +17.1% |
Range$0.00 – $1.91B
Avg YoY Growth-41.4%
Median YoY Growth-41.4%
Current Streak7+ quarters growth
Debt Repayments at Other Companies
Frequently Asked Questions
- What is Eli Lilly's debt repayments?
- Eli Lilly (LLY) reported debt repayments of $194.50M in Q4 2025.
- How has Eli Lilly's debt repayments changed year-over-year?
- Eli Lilly's debt repayments increased by 17.1% year-over-year, from $166.05M to $194.50M.
- What is the long-term trend for Eli Lilly's debt repayments?
- Over 4 years (2021 to 2025), Eli Lilly's debt repayments has grown at a -20.1% compound annual growth rate (CAGR), from $1.91B to $778.00M.
- What does debt repayments mean?
- The amount of cash spent to pay back the company's borrowed money.